Moderna (MRNA) Revenue
Moderna (MRNA) reported revenue of $1.9B in fiscal 2025. Since fiscal 2021 ($18.5B), it has declined 89%. The high over this period was $19.3B, in fiscal 2022.
Free: last 5 years
| Fiscal year | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | $18.5B | $19.3B | $6.8B | $3.2B | $1.9B |